In:
Pediatric Transplantation, Wiley, Vol. 24, No. 6 ( 2020-09)
Abstract:
Eplet incompatibility appears to be a better predictor of the de novo appearance of DSA post‐Tx than HLA antigen matching in adults. We evaluated the HLA Matchmaker® software (version 2.1) in our pediatric cohort to predict the appearance of DSA post‐Tx. We included 70 pediatric patients (26 girls, 10 living donors, mean age 11.2 ± 3.9 years) after a first R‐Tx (January 2010‐August 2016), without prior immunization, having complete HLA typing (A, B, C, DRB1 and DQB1) and DSA follow‐up for at least one year. The mean of HLA and eplet incompatibilities was 4.7 ± 1.3 and 15.5 ± 6.1, respectively, with a correlation coefficient r 2 between these two variables of 0.34 ( P 〈 .001). The eplet load was 12.8 ± 5.0 in living donors vs 15.9 ± 6.2 in deceased donors ( P = NS), 12.6 ± 6.1 in preemptive R‐Tx (n = 14) vs 16.3 ± 5.9 for non‐preemptive R‐Tx ( P = .04). Seven patients (10%) developed DSA during the 3.5 ± 1.2 years post‐Tx. The eplet load was 13.7 ± 5.5 for those who developed DSA vs 15.7 ± 6.1 for the others ( P = NS). In our single‐center series of pediatric R‐Tx with good HLA matching and lower eplet load than previously published series, eplet incompatibilities do not predict the development of DSA. The question of the HLA matching requirement and the daily interest of the HLA Matchmaker® software to help select the grafts remain open.
Type of Medium:
Online Resource
ISSN:
1397-3142
,
1399-3046
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2008614-3
